Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > A must watch PMX presentation by Dr. Kellum

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Jul 12, 2022 9:28am

151 Views

Post# 34817570

RE:RE:RE:RE:RE:A must watch PMX presentation by Dr. Kellum

I have also intentionally neglected to include EAA diagnostic revenues in the PMX revenue calculations.

Again massive but un quantifiable. But MASSIVE!....and they own 100% of EAA's global rights.

It will take newbies a bit of work to understand precisely what they are looking at but MASSIVE is the word that always comes to mind as I study Spectral's revenue opportunity.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario